Annual Long Term Debt
$490.00 K
-$770.00 K-61.11%
December 31, 2023
Summary
- As of February 8, 2025, RYTM annual long term debt is $490.00 thousand, with the most recent change of -$770.00 thousand (-61.11%) on December 31, 2023.
- During the last 3 years, RYTM annual long term debt has fallen by -$2.06 million (-80.79%).
- RYTM annual long term debt is now -84.12% below its all-time high of $3.09 million, reached on December 31, 2019.
Performance
RYTM Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$4.03 M
+$729.00 K+22.08%
September 30, 2024
Summary
- As of February 8, 2025, RYTM quarterly long term debt is $4.03 million, with the most recent change of +$729.00 thousand (+22.08%) on September 30, 2024.
- Over the past year, RYTM quarterly long term debt has increased by +$3.75 million (+1319.01%).
- RYTM quarterly long term debt is now at all-time high.
Performance
RYTM Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RYTM Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -61.1% | +1319.0% |
3 y3 years | -80.8% | +107.2% |
5 y5 years | +100.0% | +107.2% |
RYTM Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -74.8% | at low | at high | +1319.0% |
5 y | 5-year | -84.1% | at low | at high | +1319.0% |
alltime | all time | -84.1% | -100.0% | at high | -100.0% |
Rhythm Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.03 M(+22.1%) |
Jun 2024 | - | $3.30 M(+1062.3%) |
Mar 2024 | - | $284.00 K(-42.0%) |
Dec 2023 | $490.00 K(-61.1%) | $490.00 K(-29.2%) |
Sep 2023 | - | $692.00 K(-22.1%) |
Jun 2023 | - | $888.00 K(-17.5%) |
Mar 2023 | - | $1.08 M(-14.6%) |
Dec 2022 | $1.26 M(-35.2%) | $1.26 M(-12.5%) |
Sep 2022 | - | $1.44 M(-10.8%) |
Jun 2022 | - | $1.61 M(-9.4%) |
Mar 2022 | - | $1.78 M(-8.4%) |
Dec 2021 | $1.95 M | $1.95 M(-7.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $2.10 M(-6.8%) |
Jun 2021 | - | $2.26 M(-6.2%) |
Mar 2021 | - | $2.41 M(-5.7%) |
Dec 2020 | $2.55 M(-17.3%) | $2.55 M(-5.2%) |
Sep 2020 | - | $2.69 M(-4.8%) |
Jun 2020 | - | $2.83 M(-4.4%) |
Mar 2020 | - | $2.96 M(-4.1%) |
Dec 2019 | $3.09 M(>+9900.0%) | $3.09 M(-3.9%) |
Sep 2019 | - | $3.21 M(-3.6%) |
Jun 2019 | - | $3.33 M(-3.3%) |
Mar 2019 | - | $3.45 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Rhythm Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual long term debt year-on-year change?
- What is Rhythm Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly long term debt year-on-year change?
What is Rhythm Pharmaceuticals annual long term debt?
The current annual long term debt of RYTM is $490.00 K
What is the all time high annual long term debt for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual long term debt is $3.09 M
What is Rhythm Pharmaceuticals annual long term debt year-on-year change?
Over the past year, RYTM annual long term debt has changed by -$770.00 K (-61.11%)
What is Rhythm Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of RYTM is $4.03 M
What is the all time high quarterly long term debt for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly long term debt is $4.03 M
What is Rhythm Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, RYTM quarterly long term debt has changed by +$3.75 M (+1319.01%)